Can a Drug-Coated balloon keep heart arteries open for a decade?

NCT ID NCT06620458

First seen Aug 18, 2026 · Last updated Aug 18, 2026

Summary

This study follows about 5,000 people with coronary artery disease who are treated with a paclitaxel drug-coated balloon angioplasty, a procedure that opens narrowed heart arteries and releases medication to help keep them open. Researchers are combining past medical records with new data, including blood samples and imaging, to identify factors that predict long-term success. Participants will be tracked for up to 10 years to see how often major heart events occur and how durable the treatment is.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Paclitaxel drug-coated balloon angioplasty
What this could lead to
If successful, this could help doctors predict which patients with coronary artery disease will benefit most from drug-coated balloon angioplasty, improving long-term outcomes.
What could go wrong
This is an observational study, not a randomized trial, so it cannot prove cause and effect. Results may be influenced by patient differences, and long-term follow-up may be incomplete.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fuwai Central China Cardiovascular Hospital

    Zhengzhou, China, 450003, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.